Quotient Limited Ordinary Shares
QTNT wurde am 30. Dezember 2022 von der Börse genommen.
Profil: Quotient Ltd is a commercial-stage diagnostics company. It is involved in the development, manufacturing, and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company develops and commercializes the Mosaiq automation platform. Its product portfolio includes Reagent Red Blood Cells, Antisera Products, Whole Blood Controls, and Ancillary Products. The firm operates in Edinburgh, Scotland, Eysins, Switzerland, and Newton, Pennsylvania. It derives the majority of its revenue from the United States.
Mitarbeiter: 450
Nachrichten
Für QTNT liegen uns keine aktuellen Nachrichtenartikel vor.